
Home » Prescription Drugs 15 » TEGRETOL Carbatrol
Carbamazepine is used alone or in combination with other medications to treat certain types of seizures in patients with epilepsy. It is also used to treat trigeminal neuralgia (a condition that causes facial nerve pain). Carbamazepine extended-release capsules (Equetro brand only) are used to treat episodes of mania (frenzied abnormally excited or irritated mood) or mixed episodes (symptoms of mania and depression that happen at the same time) in patients with bipolar I disorder (manic-depressive disorder; a disease that causes episodes of depression episodes of mania and other abnormal moods).Carbamazepine is in a class of medications called anticonvulsants. It works by reducing abnormal excitement in the brain.
Buy TEGRETOL Carbatrol and other Prescription Drugs 15 products online
at Medstore.
Buy Online at Medstore - Click Here!

About TEGRETOL Carbatrol:
Product Type: Prescription Drugs 15
TEGRETOL ( Carbatrol Equetrol Atretol Depitol Epitol Generic Carbamazepine )
TEGRETOL (Carbatrol Equetrol Atretol Depitol Epitol Generic Carbamazepine)
Carbatrol Equetrol Atretol Depitol Epitol Generic Carbamazepine
100mg Tabs
Carbatrol Equetrol Atretol Depitol Epitol Generic Carbamazepine TEGRETOL

View more
Prescription Drugs 15
Previous Product Next Product
Pharmacy:
Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide:
Which drugs are scheduled to go generic?
Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.


|